Clifford David Jones

USPTO Granted Patents = 14 (Patent Applications = 13)

CIPO Patents = 1 (Patent Applications = 3)

EPO Patents = 5 (Patent Applications = 16)

Average Co-Inventor Count = 5.2

ph-index = 3

Forward Citations = 49(Granted Patents)

Location History:

Cheshire, GB (2008 - 2019)
Macclesfield, GB (2008 - 2024)

Company Filing History:

Jazz Pharmaceuticals Ireland Limited

patents

Years Active: 2008-2025

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12453734 - Modulators of rho-associated protein kinase (2025-10-28),

2. 12304912 - Fused bicyclic RAF inhibitors and methods for use thereof (2025-05-20),

3. 11878020 - Modulators of Rho-associated protein kinase (2024-01-23),

4. 11858930 - Fused bicyclic RAF inhibitors and methods for use thereof (2024-01-02),

5. 11497751 - Modulators of Rho-associated protein kinase (2022-11-15),

6. 10202391 - Chemical compounds (2019-02-12),

7. 9902731 - Chemical compounds (2018-02-27),

8. 8569298 - Pyridine compounds (2013-10-29),

9. 7951830 - Compounds effecting glucokinase (2011-05-31),

10. 7745428 - Imidazo[1,2-A]pyridine having anti-cell-proliferation activity (2010-06-29),

11. 7524957 - Compounds effecting glucokinase (2009-04-28),

12. 7476677 - Substituted thieno- and thiazolo- [2,3-d]pyrimidines and [2,3-c]pyridines as inhibitors of Tie2 (2009-01-13),

13. 7427616 - Condensed pyridines and pyrimidines with tie2 (TEK) activity (2008-09-23),

14. 7390908 - Compounds effecting glucokinase (2008-06-24),

Title: The Innovative Journey of Clifford David Jones

Introduction

Clifford David Jones is an accomplished inventor based in Macclesfield, GB, known for his significant contributions to the field of pharmaceuticals with a total of 13 patents to his name. His work focuses on developing innovative compounds aimed at treating serious diseases, including various forms of cancer.

Latest Patents

Among Clifford's most recent patents are groundbreaking advancements in the synthesis of fused bicyclic Raf inhibitors. This innovative compound targets multiple formula variations and provides a promising method for treating diseases such as colorectal cancer. Another notable patent involves modulators of Rho-associated protein kinase (ROCK), for which he has developed novel compounds and pharmaceutical compositions that hold potential in treating ROCK-mediated diseases, showing his commitment to addressing critical healthcare challenges.

Career Highlights

Clifford has built a distinguished career in the pharmaceutical sector, with pivotal roles in renowned companies such as AstraZeneca and Jazz Pharmaceuticals Ireland Limited. His expertise in drug development has led to notable advancements in treatment options for various conditions, showcasing his innovative spirit and dedication to improving patient outcomes.

Collaborations

Throughout his career, Clifford has collaborated with esteemed colleagues, including Scott Boyd and Peter William Rodney Caulkett. These partnerships have further enhanced his research and development efforts, resulting in a robust portfolio of patents that represent significant scientific advancements in pharmaceuticals.

Conclusion

Clifford David Jones stands out as a prominent figure in the field of invention and innovation, particularly in the pharmaceutical industry. His extensive work and achievements not only reflect his expertise and dedication to research but also highlight the impactful contributions he has made toward advancements in medical treatments. His ongoing commitment to innovation continues to pave the way for new possibilities in healthcare.

This text is generated by artificial intelligence and may not be accurate.